Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 234

1.

Proteasome protease mediated regulation of cytokine induction and inflammation.

Qureshi N, Morrison DC, Reis J.

Biochim Biophys Acta. 2012 Nov;1823(11):2087-93. doi: 10.1016/j.bbamcr.2012.06.016. Epub 2012 Jun 19. Review.

2.

Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor.

Qureshi AA, Guan XQ, Reis JC, Papasian CJ, Jabre S, Morrison DC, Qureshi N.

Lipids Health Dis. 2012 Jul 10;11:76. doi: 10.1186/1476-511X-11-76.

3.

Inhibition of nitric oxide in LPS-stimulated macrophages of young and senescent mice by δ-tocotrienol and quercetin.

Qureshi AA, Tan X, Reis JC, Badr MZ, Papasian CJ, Morrison DC, Qureshi N.

Lipids Health Dis. 2011 Dec 20;10:239. doi: 10.1186/1476-511X-10-239.

4.

Suppression of nitric oxide induction and pro-inflammatory cytokines by novel proteasome inhibitors in various experimental models.

Qureshi AA, Tan X, Reis JC, Badr MZ, Papasian CJ, Morrison DC, Qureshi N.

Lipids Health Dis. 2011 Oct 12;10:177. doi: 10.1186/1476-511X-10-177.

5.

Tocotrienols-induced inhibition of platelet thrombus formation and platelet aggregation in stenosed canine coronary arteries.

Qureshi AA, Karpen CW, Qureshi N, Papasian CJ, Morrison DC, Folts JD.

Lipids Health Dis. 2011 Apr 14;10:58. doi: 10.1186/1476-511X-10-58.

6.

LPS-induced formation of immunoproteasomes: TNF-α and nitric oxide production are regulated by altered composition of proteasome-active sites.

Reis J, Guan XQ, Kisselev AF, Papasian CJ, Qureshi AA, Morrison DC, Van Way CW 3rd, Vogel SN, Qureshi N.

Cell Biochem Biophys. 2011 Jun;60(1-2):77-88. doi: 10.1007/s12013-011-9182-8.

7.

The immunoproteasomes regulate LPS-induced TRIF/TRAM signaling pathway in murine macrophages.

Reis J, Hassan F, Guan XQ, Shen J, Monaco JJ, Papasian CJ, Qureshi AA, Van Way CW 3rd, Vogel SN, Morrison DC, Qureshi N.

Cell Biochem Biophys. 2011 Jun;60(1-2):119-26. doi: 10.1007/s12013-011-9183-7.

8.

δ-Tocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens.

Qureshi AA, Reis JC, Qureshi N, Papasian CJ, Morrison DC, Schaefer DM.

Lipids Health Dis. 2011 Feb 28;10:39. doi: 10.1186/1476-511X-10-39.

9.

Tocotrienols inhibit lipopolysaccharide-induced pro-inflammatory cytokines in macrophages of female mice.

Qureshi AA, Reis JC, Papasian CJ, Morrison DC, Qureshi N.

Lipids Health Dis. 2010 Dec 16;9:143. doi: 10.1186/1476-511X-9-143.

10.

Prefeeding with omega-3 fatty acids suppresses inflammation following hemorrhagic shock.

Yang R, Harris WS, Vernon K, Thomas AM, Qureshi N, Morrison DC, Van Way CW 3rd.

JPEN J Parenter Enteral Nutr. 2010 Sep-Oct;34(5):496-502. doi: 10.1177/0148607110362994.

PMID:
20852177
11.

Lipid A-mediated tolerance and cancer therapy.

Rockwell CE, Morrison DC, Qureshi N.

Adv Exp Med Biol. 2010;667:81-99. doi: 10.1007/978-1-4419-1603-7_8.

12.

The proteasome regulates bacterial CpG DNA-induced signaling pathways in murine macrophages.

Gao JJ, Shen J, Kolbert C, Raghavakaimal S, Papasian CJ, Qureshi AA, Vogel SN, Morrison DC, Qureshi N.

Shock. 2010 Oct;34(4):390-401. doi: 10.1097/SHK.0b013e3181d884ea.

13.

A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model.

Reis J, Tan X, Yang R, Rockwell CE, Papasian CJ, Vogel SN, Morrison DC, Qureshi AA, Qureshi N.

Innate Immun. 2008 Oct;14(5):319-29. doi: 10.1177/1753425908096855.

14.

Hemorrhagic shock in the rat: comparison of carotid and femoral cannulation.

Yang R, Tan X, Kenney RJ Jr, Thomas A, Landis M, Qureshi N, Morrison DC, Van Way CW 3rd.

J Surg Res. 2008 Jan;144(1):124-6. Epub 2007 Jun 8.

PMID:
17560609
15.

Alanine-glutamine dipeptide (AGD) inhibits expression of inflammation-related genes in hemorrhagic shock.

Yang R, Tan X, Thomas AM, Steppacher R, Qureshi N, Morrison DC, Van Way CW 3rd.

JPEN J Parenter Enteral Nutr. 2007 Jan-Feb;31(1):32-6.

PMID:
17202438
16.

Effect of DHEA on the hemodynamic response to resuscitation in a porcine model of hemorrhagic shock.

Yang R, Tibbs BM, Chang B, Nguyen C, Woodall C, Steppacher R, Helling T, Morrison DC, Van Way CW 3rd.

J Trauma. 2006 Dec;61(6):1343-9.

PMID:
17159675
17.

Crocetin inhibits mRNA expression for tumor necrosis factor-alpha, interleukin-1beta, and inducible nitric oxide synthase in hemorrhagic shock.

Yang R, Tan X, Thomas AM, Shen J, Qureshi N, Morrison DC, Van Way CW 3rd.

JPEN J Parenter Enteral Nutr. 2006 Jul-Aug;30(4):297-301.

PMID:
16804126
18.

Proteasome-mediated regulation of CpG DNA- and peptidoglycan-induced cytokines, inflammatory genes, and mitogen-activated protein kinase activation.

Shen J, Gao JJ, Zhang G, Tan X, Morrison DC, Papasian C, Vogel SN, Qureshi N.

Shock. 2006 Jun;25(6):594-9.

PMID:
16721267
19.

Key inflammatory signaling pathways are regulated by the proteasome.

Shen J, Reis J, Morrison DC, Papasian C, Raghavakaimal S, Kolbert C, Qureshi AA, Vogel SN, Qureshi N.

Shock. 2006 May;25(5):472-84. Erratum in: Shock. 2006 Sep;26(3):318.

PMID:
16680012
20.

Endogenous and exogenous glucocorticoids in experimental enterococcal infection.

Papasian CJ, Qureshi N, Morrison DC.

Clin Vaccine Immunol. 2006 Mar;13(3):349-55.

21.

Regulation of cellular caveolin-1 protein expression in murine macrophages by microbial products.

Lei MG, Tan X, Qureshi N, Morrison DC.

Infect Immun. 2005 Dec;73(12):8136-43.

22.

Serum-dependent potentiation of lipopolysaccharide-induced nitric oxide production is mediated by the events after the transcription of inducible type of nitric oxide synthase.

Zhang YH, Murphy WJ, Russell SW, Morrison DC, Koide N, Yoshida T, Yokochi T.

Cell Immunol. 2005 Mar;234(1):16-22.

PMID:
15936007
23.

The proteasome: a central regulator of inflammation and macrophage function.

Qureshi N, Vogel SN, Van Way C 3rd, Papasian CJ, Qureshi AA, Morrison DC.

Immunol Res. 2005;31(3):243-60. Review.

PMID:
15888915
24.

Pathogenesis of sepsis: current concepts and emerging therapies.

Lei MG, Gao JJ, Morrison DC, Qureshi N.

Mo Med. 2003 Sep-Oct;100(5):524-9. Review.

PMID:
14601445
25.

Bacterial LPS and CpG DNA differentially induce gene expression profiles in mouse macrophages.

Gao JJ, Diesl V, Wittmann T, Morrison DC, Ryan JL, Vogel SN, Follettie MT.

J Endotoxin Res. 2003;9(4):237-43.

PMID:
12935354
27.

The proteasome as a lipopolysaccharide-binding protein in macrophages: differential effects of proteasome inhibition on lipopolysaccharide-induced signaling events.

Qureshi N, Perera PY, Shen J, Zhang G, Lenschat A, Splitter G, Morrison DC, Vogel SN.

J Immunol. 2003 Aug 1;171(3):1515-25.

28.

Cellular energetics in hemorrhagic shock: restoring adenosine triphosphate to the cells.

Van Way CW 3rd, Dhar A, Morrison DC, Longorio MA, Maxfield DM.

J Trauma. 2003 May;54(5 Suppl):S169-76.

PMID:
12768121
29.

Regulation of gene expression in mouse macrophages stimulated with bacterial CpG-DNA and lipopolysaccharide.

Gao JJ, Diesl V, Wittmann T, Morrison DC, Ryan JL, Vogel SN, Follettie MT.

J Leukoc Biol. 2002 Dec;72(6):1234-45.

PMID:
12488506
30.

Anomalous role of tumor necrosis factor alpha in experimental enterococcal infection.

Papasian CJ, Silverstein R, Gao JJ, Bamberger DM, Morrison DC.

Infect Immun. 2002 Dec;70(12):6628-37.

31.

Fabrication of an educational model for patients considering prostheses retained by osseointegrated implants.

Morrison DC, Kubon TM, Anderson J.

J Prosthet Dent. 2002 Jun;87(6):679-83.

PMID:
12131892
32.

Alteration of surfactant proteins A and D in bronchoalveolar lavage fluid of Pneumocystis carinii pneumonia.

Qu J, He L, Rong Z, Pan J, Chen X, Morrison DC, Li X.

Chin Med J (Engl). 2001 Nov;114(11):1143-6.

PMID:
11729507
33.

Lipopolyamines as a therapeutic strategy in experimental Gram-negative bacterial sepsis.

Opal SM, Palardy JE, Parejo N, Morrison DC.

J Endotoxin Res. 2001;7(1):35-8.

PMID:
11521079
34.
35.

Interleukin-6 production by endothelial cells via stimulation of protease-activated receptors is amplified by endotoxin and tumor necrosis factor-alpha.

Chi L, Li Y, Stehno-Bittel L, Gao J, Morrison DC, Stechschulte DJ, Dileepan KN.

J Interferon Cytokine Res. 2001 Apr;21(4):231-40.

PMID:
11359654
36.
37.

A comparative trial of imipenem versus ceftazidime in the release of endotoxin and cytokine generation in patients with gram-negative urosepsis. Urosepsis Study Group.

Luchi M, Morrison DC, Opal S, Yoneda K, Slotman G, Chambers H, Wiesenfeld H, Lemke J, Ryan JL, Horn D.

J Endotoxin Res. 2000;6(1):25-31.

PMID:
11061029
38.

What are the microbial components implicated in the pathogenesis of sepsis? Report on a symposium.

Horn DL, Morrison DC, Opal SM, Silverstein R, Visvanathan K, Zabriskie JB.

Clin Infect Dis. 2000 Oct;31(4):851-8. Epub 2000 Oct 11. Review.

PMID:
11049761
39.
41.

Prenatally drug-exposed toddlers: cognitive and social development.

Morrison DC, Cerles L, Montaini-Klovdahl L, Skowron E.

Am J Orthopsychiatry. 2000 Apr;70(2):278-83.

PMID:
10826040
42.

Differential host inflammatory responses to viable versus antibiotic-killed bacteria in experimental microbial sepsis.

Silverstein R, Wood JG, Xue Q, Norimatsu M, Horn DL, Morrison DC.

Infect Immun. 2000 Apr;68(4):2301-8.

44.

Preparation of endotoxin from pathogenic gram-negative bacteria.

Shnyra A, Luchi M, Morrison DC.

Methods Mol Med. 2000;36:13-25. doi: 10.1385/1-59259-216-3:13.

PMID:
21340960
45.

Cutting edge: bacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264.7 macrophages.

Gao JJ, Zuvanich EG, Xue Q, Horn DL, Silverstein R, Morrison DC.

J Immunol. 1999 Oct 15;163(8):4095-9.

46.

Structure-function relationships of bacterial endotoxins. Contribution to microbial sepsis.

Morrison DC, Silverstein R, Luchi M, Shnyra A.

Infect Dis Clin North Am. 1999 Jun;13(2):313-40. Review.

PMID:
10340169
47.

Lipopolyamines: novel antiendotoxin compounds that reduce mortality in experimental sepsis caused by gram-negative bacteria.

David SA, Silverstein R, Amura CR, Kielian T, Morrison DC.

Antimicrob Agents Chemother. 1999 Apr;43(4):912-9.

48.
49.

Differential regulation of lipopolysaccharide (LPS) activation pathways in mouse macrophages by LPS-binding proteins.

Amura CR, Kamei T, Ito N, Soares MJ, Morrison DC.

J Immunol. 1998 Sep 1;161(5):2552-60.

Supplemental Content

Loading ...
Support Center